{"id":3798,"date":"2026-09-29T07:00:48","date_gmt":"2026-09-29T12:00:48","guid":{"rendered":"https:\/\/www.molllawgroup.com\/blog\/?p=3798"},"modified":"2026-09-15T09:44:57","modified_gmt":"2026-09-15T14:44:57","slug":"studies-of-pregabalin-lyrica-show-a-risk-of-dementia","status":"publish","type":"post","link":"https:\/\/www.molllawgroup.com\/blog\/studies-of-pregabalin-lyrica-show-a-risk-of-dementia\/","title":{"rendered":"Studies of Pregabalin\/Lyrica Show a Risk of Dementia"},"content":{"rendered":"

\"mahmoud-ahmed-rendering-5276173-scaled-e1789337376742\"Pregabalin is a drug also known by the brand name Lyrica. It\u2019s used to treat epilepsy and nerve pain. It is sometimes used off label to treat chronic back pain, anxiety, or insomnia. Several studies show that pregabalin use is linked to cognitive decline. A study<\/a> of 2 million people in Taiwan also shows that there is a link to increased risk of dementia, one of the most prevalent neurodegenerative disorders worldwide, which causes progressive impairments in executive function, memory, learning, and ability to perform daily activities. The research data for the study, which also included gabapentin, was collected from January 2000\u2013December 2017. Around 206,802 patients were involved with the study. Around 34,467 of those taking pregabalin or gabapentin and 172,335 non-exposed people were analyzed. The risk of dementia increased with higher cumulative daily doses during a follow-up period. Moreover, the risk of dementia associated with pregabalin exposure was higher in patients under the age of 50 than older patients. If a loved one is experiencing dementia or cognitive decline and you believe it\u2019s the result of exposure to pregabalin, you should consult the seasoned Chicago-based product liability attorneys of Moll Law Group to determine whether you have a viable claim.<\/p>\n

Contact Moll Law Group About Your Pregabalin or Lyrica Claim<\/strong><\/p>\n

Originally, pregabalin was approved for neuropathic pain and partial seizures. However, it is increasingly used off-label, and often it\u2019s prescribed for young people. Numerous factors can go into the risk of developing dementia, and around 50 million people live with dementia around the world. The prevalence of dementia is rising, and so the increase in pregabalin prescriptions and the associated cognitive adverse effects is of particular concern.<\/p>\n

Continue reading \u2192<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"

Pregabalin is a drug also known by the brand name Lyrica. It\u2019s used to treat epilepsy and nerve pain. It is sometimes used off label to treat chronic back pain, anxiety, or insomnia. Several studies show that pregabalin use is linked to cognitive decline. A study of 2 million people in Taiwan also shows that […]<\/p>\n","protected":false},"author":2,"featured_media":3800,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[],"class_list":["post-3798","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-prescription-drug-injuries"],"yoast_head":"\nStudies of Pregabalin\/Lyrica Show a Risk of Dementia — Illinois Injury and Mass Tort Lawyer Blog — September 29, 2026<\/title>\n<meta name=\"description\" content=\"Pregabalin is a drug also known by the brand name Lyrica. It\u2019s used to treat epilepsy and nerve pain. It is sometimes used off label to treat chronic back — September 29, 2026\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.molllawgroup.com\/blog\/studies-of-pregabalin-lyrica-show-a-risk-of-dementia\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Studies of Pregabalin\/Lyrica Show a Risk of Dementia — Illinois Injury and Mass Tort Lawyer Blog — September 29, 2026\" \/>\n<meta name=\"twitter:description\" content=\"Pregabalin is a drug also known by the brand name Lyrica. It\u2019s used to treat epilepsy and nerve pain. It is sometimes used off label to treat chronic back — September 29, 2026\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2026\/09\/mahmoud-ahmed-rendering-5276173-scaled-e1789337376742.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Moll Law Group\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Studies of Pregabalin\/Lyrica Show a Risk of Dementia — Illinois Injury and Mass Tort Lawyer Blog — September 29, 2026","description":"Pregabalin is a drug also known by the brand name Lyrica. It\u2019s used to treat epilepsy and nerve pain. It is sometimes used off label to treat chronic back — September 29, 2026","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.molllawgroup.com\/blog\/studies-of-pregabalin-lyrica-show-a-risk-of-dementia\/","twitter_card":"summary_large_image","twitter_title":"Studies of Pregabalin\/Lyrica Show a Risk of Dementia — Illinois Injury and Mass Tort Lawyer Blog — September 29, 2026","twitter_description":"Pregabalin is a drug also known by the brand name Lyrica. It\u2019s used to treat epilepsy and nerve pain. It is sometimes used off label to treat chronic back — September 29, 2026","twitter_image":"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2026\/09\/mahmoud-ahmed-rendering-5276173-scaled-e1789337376742.jpg","twitter_misc":{"Written by":"Moll Law Group","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.molllawgroup.com\/blog\/studies-of-pregabalin-lyrica-show-a-risk-of-dementia\/#article","isPartOf":{"@id":"https:\/\/www.molllawgroup.com\/blog\/studies-of-pregabalin-lyrica-show-a-risk-of-dementia\/"},"author":{"name":"Moll Law Group","@id":"https:\/\/www.molllawgroup.com\/blog\/#\/schema\/person\/53d2eb37d5d0cdb46ac61abacf05ce90"},"headline":"Studies of Pregabalin\/Lyrica Show a Risk of Dementia","datePublished":"2026-09-29T12:00:48+00:00","mainEntityOfPage":{"@id":"https:\/\/www.molllawgroup.com\/blog\/studies-of-pregabalin-lyrica-show-a-risk-of-dementia\/"},"wordCount":528,"image":{"@id":"https:\/\/www.molllawgroup.com\/blog\/studies-of-pregabalin-lyrica-show-a-risk-of-dementia\/#primaryimage"},"thumbnailUrl":"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2026\/09\/mahmoud-ahmed-rendering-5276173-scaled-e1789337376742.jpg","articleSection":["Prescription Drug Injuries"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.molllawgroup.com\/blog\/studies-of-pregabalin-lyrica-show-a-risk-of-dementia\/","url":"https:\/\/www.molllawgroup.com\/blog\/studies-of-pregabalin-lyrica-show-a-risk-of-dementia\/","name":"Studies of Pregabalin\/Lyrica Show a Risk of Dementia — Illinois Injury and Mass Tort Lawyer Blog — September 29, 2026","isPartOf":{"@id":"https:\/\/www.molllawgroup.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.molllawgroup.com\/blog\/studies-of-pregabalin-lyrica-show-a-risk-of-dementia\/#primaryimage"},"image":{"@id":"https:\/\/www.molllawgroup.com\/blog\/studies-of-pregabalin-lyrica-show-a-risk-of-dementia\/#primaryimage"},"thumbnailUrl":"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2026\/09\/mahmoud-ahmed-rendering-5276173-scaled-e1789337376742.jpg","datePublished":"2026-09-29T12:00:48+00:00","author":{"@id":"https:\/\/www.molllawgroup.com\/blog\/#\/schema\/person\/53d2eb37d5d0cdb46ac61abacf05ce90"},"description":"Pregabalin is a drug also known by the brand name Lyrica. It\u2019s used to treat epilepsy and nerve pain. It is sometimes used off label to treat chronic back — September 29, 2026","breadcrumb":{"@id":"https:\/\/www.molllawgroup.com\/blog\/studies-of-pregabalin-lyrica-show-a-risk-of-dementia\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.molllawgroup.com\/blog\/studies-of-pregabalin-lyrica-show-a-risk-of-dementia\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.molllawgroup.com\/blog\/studies-of-pregabalin-lyrica-show-a-risk-of-dementia\/#primaryimage","url":"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2026\/09\/mahmoud-ahmed-rendering-5276173-scaled-e1789337376742.jpg","contentUrl":"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2026\/09\/mahmoud-ahmed-rendering-5276173-scaled-e1789337376742.jpg","width":600,"height":400},{"@type":"BreadcrumbList","@id":"https:\/\/www.molllawgroup.com\/blog\/studies-of-pregabalin-lyrica-show-a-risk-of-dementia\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.molllawgroup.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Studies of Pregabalin\/Lyrica Show a Risk of Dementia"}]},{"@type":"WebSite","@id":"https:\/\/www.molllawgroup.com\/blog\/#website","url":"https:\/\/www.molllawgroup.com\/blog\/","name":"Illinois Injury and Mass Tort Lawyer Blog","description":"Published by Illinois Injury and Mass Tort Attorney \u2014 Moll Law Group","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.molllawgroup.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.molllawgroup.com\/blog\/#\/schema\/person\/53d2eb37d5d0cdb46ac61abacf05ce90","name":"Moll Law Group","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/0febdc96ea554e620e775358f9d7e4fc56616188dfd2bb21b18c2fed4bd185a0?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/0febdc96ea554e620e775358f9d7e4fc56616188dfd2bb21b18c2fed4bd185a0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0febdc96ea554e620e775358f9d7e4fc56616188dfd2bb21b18c2fed4bd185a0?s=96&d=mm&r=g","caption":"Moll Law Group"}}]}},"jetpack_featured_media_url":"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2026\/09\/mahmoud-ahmed-rendering-5276173-scaled-e1789337376742.jpg","_links":{"self":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts\/3798","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/comments?post=3798"}],"version-history":[{"count":1,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts\/3798\/revisions"}],"predecessor-version":[{"id":3801,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts\/3798\/revisions\/3801"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/media\/3800"}],"wp:attachment":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/media?parent=3798"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/categories?post=3798"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/tags?post=3798"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}